{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:38:30Z","timestamp":1792521510654,"version":"4.5.0"},"reference-count":185,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok, Poland","award":["B.SUB.23.395"],"award-info":[{"award-number":["B.SUB.23.395"]}]},{"name":"Medical University of Bialystok, Poland","award":["B.SUB.23.394"],"award-info":[{"award-number":["B.SUB.23.394"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a progressive, currently incurable disease characterized by elevated pulmonary arterial pressure, vascular remodeling, and right ventricular hypertrophy, eventually leading to heart failure and death. Sirtuin 1 (SIRT1), a NAD+-dependent deacetylase, regulates endothelial and vascular smooth muscle function, and its activation by compounds such as resveratrol or SRT1720 shows therapeutic potential by reducing pulmonary and right ventricular pressures and limiting vascular remodeling in both preventive and therapeutic experimental models, highlighting their potential translational relevance. To date, no comprehensive review has focused on the role of SIRT1 in PAH. This review summarizes the molecular mechanisms of SIRT1 action in the cardiopulmonary system and discusses its therapeutic potential in PAH treatment.<\/jats:p>","DOI":"10.3390\/molecules30183740","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T16:27:33Z","timestamp":1757953653000},"page":"3740","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Can Sirtuin 1 Serve as a Therapeutic Target in Pulmonary Arterial Hypertension? A Comprehensive Review"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1794-9947","authenticated-orcid":false,"given":"Sandra","family":"Budziak","sequence":"first","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bia\u0142ystok, 15-222 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7374-0999","authenticated-orcid":false,"given":"Monika","family":"Kloza","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bia\u0142ystok, 15-222 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-3757","authenticated-orcid":false,"given":"Anna","family":"Krzy\u017cewska","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bia\u0142ystok, 15-222 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-2656","authenticated-orcid":false,"given":"Marta","family":"Baranowska-Kuczko","sequence":"additional","affiliation":[{"name":"Department of Experimental Physiology and Pathophysiology, Medical University of Bia\u0142ystok, 15-222 Bia\u0142ystok, Poland"},{"name":"Department of Clinical Pharmacy, Medical University of Bia\u0142ystok, 15-222 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2401095","DOI":"10.1183\/13993003.01095-2024","article-title":"Pathology and pathobiology of pulmonary hypertension: Current insights and future directions","volume":"64","author":"Guignabert","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Campagna, R., and Vignini, A. (2023). NAD+ homeostasis and NAD+-consuming enzymes: Implications for vascular health. Antioxidant, 12.","DOI":"10.3390\/antiox12020376"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1152\/ajpheart.00001.2024","article-title":"Dual-edged role of SIRT1 in energy metabolism and cardiovascular disease","volume":"327","author":"Zhou","year":"2024","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/HJH.0000000000001676","article-title":"Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: Role in pulmonary arterial hypertension","volume":"36","author":"Zurlo","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/HJH.0000000000001694","article-title":"Sirtuin 1 as a potential therapeutic target in pulmonary artery hypertension","volume":"36","author":"Cheng","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kurakula, K., Smolders, V., Tura-Ceide, O., Jukema, J.W., Quax, P.H.A., and Goumans, M.J. (2021). Endothelial dysfunction in pulmonary hypertension: Cause or consequence?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010057"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jacasi.2022.09.010","article-title":"Pathogenic mechanisms of pulmonary arterial hypertension: Homeostasis imbalance of endothelium-derived relaxing and contracting factors","volume":"2","author":"Zhu","year":"2022","journal-title":"JACC Asia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e000137","DOI":"10.1136\/bmjmed-2022-000137","article-title":"Pathophysiology and new advances in pulmonary hypertension","volume":"2","author":"Bousseau","year":"2023","journal-title":"BMJ Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.118.035326","article-title":"Right ventricular fibrosis","volume":"139","author":"Andersen","year":"2019","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hu, Y., Chi, L., Kuebler, W.M., and Goldenberg, N.M. (2020). Perivascular inflammation in pulmonary arterial hypertension. Cells, 9.","DOI":"10.3390\/cells9112338"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Xu, D., Hu, Y.H., Gou, X., Li, F.Y., Yang, X.Y., Li, Y.M., and Chen, F. (2022). Oxidative stress and antioxidative therapy in pulmonary arterial hypertension. Molecules, 27.","DOI":"10.3390\/molecules27123724"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eabn2743","DOI":"10.1126\/scisignal.abn2743","article-title":"Cross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension","volume":"15","author":"Shen","year":"2022","journal-title":"Sci. Signal."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, S.F., Nambiar Veetil, N., Li, Q., Kucherenko, M.M., Knosalla, C., and Kuebler, W.M. (2022). Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.959209"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"106238","DOI":"10.1016\/j.phrs.2022.106238","article-title":"Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective","volume":"180","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/abbs\/gmx095","article-title":"Immune cells and autoantibodies in pulmonary arterial hypertension","volume":"49","author":"Li","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern age pathology of pulmonary arterial hypertension","volume":"186","author":"Stacher","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"186","author":"Savai","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhao, H., Song, J., Li, X., Xia, Z., Wang, Q., Fu, J., Miao, Y., Wang, D., and Wang, X. (2024). The role of immune cells and inflammation in pulmonary hypertension: Mechanisms and implications. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1374506"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"106860","DOI":"10.1016\/j.vph.2021.106860","article-title":"Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration","volume":"138","author":"Song","year":"2021","journal-title":"Vascul. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.117.031655","article-title":"Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension","volume":"136","author":"Archer","year":"2017","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, W., Liu, B., Wang, Y., Zhang, H., He, L., Wang, P., and Dong, M. (2022). Mitochondrial dysfunction in pulmonary arterial hypertension. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.1079989"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41419-022-05091-2","article-title":"FUNDC1-mediated mitophagy and HIF1\u03b1 activation drives pulmonary hypertension during hypoxia","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liang, S., Yegambaram, M., Wang, T., Wang, J., Black, S.M., and Tang, H. (2022). Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020341"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Pokharel, M.D., Marciano, D.P., Fu, P., Franco, M.C., Unwalla, H., Tieu, K., Fineman, J.R., Wang, T., and Black, S.M. (2023). Metabolic reprogramming, oxidative stress, and pulmonary hypertension. Redox Biol., 64.","DOI":"10.1016\/j.redox.2023.102797"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ryanto, G.R.T., Suraya, R., and Nagano, T. (2023). Mitochondrial Dysfunction in Pulmonary Hypertension. Antioxidants, 12.","DOI":"10.3390\/antiox12020372"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.celrep.2018.11.025","article-title":"Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication","volume":"25","author":"Ling","year":"2018","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Teixeira, C.S.S., Cerqueira, N.M.F.S.A., Gomes, P., and Sousa, S.F. (2020). A Molecular Perspective on Sirtuin Activity. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228609"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1038\/s41598-021-87759-x","article-title":"SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways","volume":"11","author":"Majeed","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kassan, M., Vikram, A., Li, Q., Kim, Y.R., Kumar, S., Gabani, M., Liu, J., Jacobs, J.S., and Irani, K. (2017). MicroRNA-204 promotes vascular endoplasmic reticulum stress and endothelial dysfunction by targeting Sirtuin1. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-06721-y"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lu, C.L., Liao, M.T., Hou, Y.C., Fang, Y.W., Zheng, C.M., Liu, W.C., Chao, C.T., Lu, K.C., and Ng, Y.Y. (2020). Sirtuin-1 and Its Relevance in Vascular Calcification. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051593"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s10020-024-00783-1","article-title":"\u03b1-Ketoglutarate improves cardiac insufficiency through NAD+-SIRT1 signaling-mediated mitophagy and ferroptosis in pressure overload-induced mice","volume":"30","author":"Yu","year":"2024","journal-title":"Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Polj\u0161ak, B., Kova\u010d, V., \u0160palj, S., and Milisav, I. (2023). The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032959"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s00018-017-2527-8","article-title":"Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells","volume":"74","author":"Hwang","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/cvr\/cvn224","article-title":"Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice","volume":"80","author":"Zhang","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCRESAHA.111.243592","article-title":"Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction","volume":"109","author":"Zhou","year":"2011","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Man, A.W.C., Li, H., and Xia, N. (2019). The Role of Sirtuin1 in Regulating Endothelial Function, Arterial Remodeling and Vascular Aging. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01173"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1101\/gad.435107","article-title":"SIRT1 controls endothelial angiogenic functions during vascular growth","volume":"21","author":"Potente","year":"2007","journal-title":"Genes Dev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Budbazar, E., Rodriguez, F., Sanchez, J.M., and Seta, F. (2020). The Role of Sirtuin-1 in the Vasculature: Focus on Aortic Aneurysm. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.01047"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCRESAHA.122.320888","article-title":"Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels","volume":"131","author":"Mengozzi","year":"2022","journal-title":"Circ. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cvr\/cvaa134","article-title":"Loss of SIRT1 in diabetes accelerates DNA damage-induced vascular calcification","volume":"117","author":"Wilkinson","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/CIRCULATIONAHA.112.124404","article-title":"Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis","volume":"127","author":"Gorenne","year":"2013","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00109-013-1111-4","article-title":"Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice","volume":"92","author":"Gao","year":"2014","journal-title":"J Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/CIRCRESAHA.116.308895","article-title":"Age-Associated Sirtuin 1 Reduction in Vascular Smooth Muscle Links Vascular Senescence and Inflammation to Abdominal Aortic Aneurysm","volume":"119","author":"Chen","year":"2016","journal-title":"Circ. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kloza, M., Krzy\u017cewska, A., Koz\u0142owska, H., Budziak, S., and Baranowska-Kuczko, M. (2025). Empagliflozin Plays Vasoprotective Role in Spontaneously Hypertensive Rats via Activation of the SIRT1\/AMPK Pathway. Cells, 14.","DOI":"10.3390\/cells14070507"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00018-020-03729-y","article-title":"Molecular mechanisms of doxorubicin-induced cardiotoxicity: Novel roles of sirtuin 1-mediated signaling pathways","volume":"78","author":"Wang","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.110.958033","article-title":"Silent information regulator 1 protects the heart from ischemia\/reperfusion","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1093\/cvr\/cvac026","article-title":"SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX","volume":"118","author":"Kuno","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12933-023-02057-2","article-title":"Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy","volume":"22","author":"Costantino","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-024-02183-5","article-title":"Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53","volume":"23","author":"Tang","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1038\/s41467-024-51318-5","article-title":"Lamin A\/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model","volume":"15","author":"Qiu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yang, Y., Liu, Y., Wang, Y., Chao, Y., Zhang, J., Jia, Y., Tie, J., and Hu, D. (2022). Regulation of SIRT1 and Its Roles in Inflammation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.831168"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wang, F., and Chen, H.Z. (2020). Histone Deacetylase SIRT1, Smooth Muscle Cell Function, and Vascular Diseases. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.537519"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCRESAHA.124.325440","article-title":"Roles of Sirtuins in Cardiovascular Diseases: Mechanisms and Therapeutics","volume":"136","author":"Ding","year":"2025","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/ars.2017.7290","article-title":"The Role of Sirtuins in Antioxidant and Redox Signaling","volume":"28","author":"Singh","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Liu, Y.P., Wen, R., Liu, C.F., Zhang, T.N., and Yang, N. (2023). Cellular and molecular biology of sirtuins in cardiovascular disease. Biomed. Pharmacother., 164.","DOI":"10.1016\/j.biopha.2023.114931"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Li, Y., Kang, K., Bao, H., Liu, S., Zhao, B., Hu, G., and Wu, J. (2025). Research Progress on the Interaction Between SIRT1 and Mitochondrial Biochemistry in the Aging of the Reproductive System. Biology, 14.","DOI":"10.3390\/biology14060643"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/jcmm.12557","article-title":"SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor \u03b21","volume":"19","author":"Mortuza","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"9636897221081479","DOI":"10.1177\/09636897221081479","article-title":"Evaluating the Effect of Circ-Sirt1 on the Expression of SIRT1 and Its Role in Pathology of Pulmonary Hypertension","volume":"31","author":"Diao","year":"2022","journal-title":"Cell Transplant."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8889195","DOI":"10.1155\/2021\/8889195","article-title":"Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1\/PIK3R1 Multiple Targets","volume":"2021","author":"Zhan","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"H458","DOI":"10.1152\/ajpheart.00366.2020","article-title":"SIRT1-mediated deacetylation of NF-\u03baB inhibits the MLCK\/MLC2 pathway and the expression of ET-1, thus alleviating the development of coronary artery spasm","volume":"320","author":"Wu","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Elmorsy, E.A., Elashry, H.A., Alkhamiss, A.S., Alsaykhan, H., Hamad, R.S., Abdel-Reheim, M.A., Alsoghair, M., Alharbi, M.S., Gabr, A.M., and Ellethy, A.T. (2025). E1231\/NMN protects against experimental metabolic syndrome: The central role of SIRT1 in modulating AKT\/Nrf2\/NF\u03baB signaling. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1558709"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cvr\/cvq339","article-title":"Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells","volume":"89","author":"Breitenstein","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Fern\u00e1ndez-Sobrino, R., Soliz-Rueda, J.R., \u00c1vila-Rom\u00e1n, J., Arola-Arnal, A., Su\u00e1rez, M., Muguerza, B., and Bravo, F.I. (2021). Blood Pressure-Lowering Effect of Wine Lees Phenolic Compounds Is Mediated by Endothelial-Derived Factors: Role of Sirtuin 1. Antioxidants, 10.","DOI":"10.3390\/antiox10071073"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"115049","DOI":"10.1016\/j.intimp.2025.115049","article-title":"Resveratrol derivative SH-707 inhibits NLRP3 inflammasome activation via a sirtuin 1-dependent pathway","volume":"161","author":"Kim","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_70","first-page":"144","article-title":"Research progress on the role of exosomes in the pathogenesis, diagnosis, and treatment of pulmonary hypertension","volume":"24","author":"Chen","year":"2023","journal-title":"Respir. Res."},{"key":"ref_71","first-page":"835","article-title":"Progress of pyroptosis in pulmonary hypertension","volume":"28","author":"Yang","year":"2023","journal-title":"Heart Fail. Rev."},{"key":"ref_72","unstructured":"Wang, H., Zhao, Q., Zhang, Y., Li, T., Zhao, M., Yang, W., and Wang, G. (2022). The role of ferroptosis in pulmonary hypertension. Front. Pharmacol., 13."},{"key":"ref_73","unstructured":"Zhao, L., Li, M., Hu, H., Liu, Z., and Zhang, Y. (2022). Mitochondria and mitochondrial regulators in the development of pulmonary hypertension. Front. Med., 9."},{"key":"ref_74","first-page":"163","article-title":"Molecular mechanisms involved in the development of pulmonary arterial hypertension (PAH)","volume":"73","author":"Li","year":"2022","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"W\u0142odarski, A., Strycharz, J., Wr\u00f3blewski, A., Kasznicki, J., Drzewoski, J., and \u015aliwi\u0144ska, A. (2020). The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186902"},{"key":"ref_76","unstructured":"Jin, Q., Xie, X., Wang, C., Zhang, W., Wang, T., Li, S., Yang, Y., Li, J., and Zhang, H. (2021). Endothelial cell metabolism in pulmonary arterial hypertension. Front. Pharmacol., 12."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Zhang, Y., He, J., Wang, Y., Chen, H., Lin, J., Zhong, C., Li, L., Huang, J., Wang, H., and Liang, G. (2023). Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of pulmonary arterial hypertension. Front. Immunol., 14.","DOI":"10.3389\/fonc.2023.1146657"},{"key":"ref_78","first-page":"L872","article-title":"Increased CD38 in the lungs of patients with pulmonary arterial hypertension","volume":"320","author":"Ho","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_79","first-page":"367","article-title":"Regulation of oxidative stress and apoptosis in pulmonary hypertension: The role of heme oxygenase-1","volume":"51","author":"Waldman","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_80","unstructured":"Hou, L., Guo, D., Wang, D., He, W., Wu, C., and Yang, J. (2023). Research progress on the mechanism of vascular remodeling in pulmonary hypertension: The role of endothelial cells and endothelial microenvironment. Biomed. Pharmacother., 159."},{"key":"ref_81","unstructured":"Guo, J., Wang, Y., Guo, H., Zhou, S., Wu, B., Zhu, L., and Wang, Y. (2022). Molecular mechanisms of vascular remodeling in idiopathic pulmonary arterial hypertension. Front. Pharmacol., 13."},{"key":"ref_82","unstructured":"Fan, C., Luo, Y., Ma, Y., Chen, Y., Li, X., Yang, W., Yang, X., Li, W., and Sun, L. (2022). Epigenetics in pulmonary hypertension: Mechanisms and therapeutic targets. Front. Genet., 13."},{"key":"ref_83","unstructured":"Scisciola, L., Fusi, F., Iside, C., Fiore, D., Liccardo, D., Iannone, M., Marfella, R., Barbieri, M., Paolisso, G., and D\u2019Onofrio, N. (2022). Epigenetic mechanisms in pulmonary arterial hypertension: The key to precision medicine. Front. Cardiovasc. Med., 9."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopha.2018.03.006","article-title":"An in vitro comparative study of the antioxidant activity and SIRT1 modulation of natural compounds","volume":"101","author":"Fusi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Iside, C., Scafuro, M., Nebbioso, A., and Altucci, L. (2020). SIRT1 Activation by Natural Phytochemicals: An Overview. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01225"},{"key":"ref_86","first-page":"1520","article-title":"Current understanding and future therapeutic prospects for pulmonary arterial hypertension with BMPR2 mutations","volume":"24","author":"Kimira","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref_87","first-page":"L293","article-title":"Pulmonary hypertension: Biomarkers and role of microRNAs","volume":"324","author":"Baskaran","year":"2023","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Ho, J.H., Baskaran, R., Wang, M.F., Mohammedsaleh, Z.M., Yang, H.S., Balasubramanian, B., and Lin, W.T. (2022). Dipeptide IF and exercise training attenuate hypertension in SHR rats by inhibiting fibrosis and hypertrophy and activating AMPK\u03b11, SIRT1, and PGC1\u03b1. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158167"},{"key":"ref_89","unstructured":"Galiniak, S., Walczak, M., Wili\u0144ska, M., Kukla, M., Michalski, \u0141., and Biesiada, G. (2021). Role of microRNAs in pulmonary arterial hypertension: Review and exploratory analysis. Biomedicines, 9."},{"key":"ref_90","first-page":"1159","article-title":"Pharmacological overview of microRNA-based drugs for pulmonary arterial hypertension","volume":"395","author":"Kumar","year":"2022","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Sharifi-Rad, J., Rayess, Y.E., Rizk, A.A., Sadaka, C., Zgheib, R., Zam, W., Sestito, S., Rapposelli, S., Neffe-Skoci\u0144ska, K., and Zieli\u0144ska, D. (2020). Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01021"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Neag, M.A., Mocan, A., Echeverr\u00eda, J., Pop, R.M., Bocsan, C.I., Cri\u015fan, G., and Buzoianu, A.D. (2018). Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00557"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","article-title":"Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases","volume":"148","author":"Park","year":"2012","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.freeradbiomed.2018.09.037","article-title":"Quercetin preserves redox status and stimulates mitochondrial function in metabolically-stressed HepG2 cells","volume":"129","author":"Houghton","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.18632\/aging.202566","article-title":"Berberine-induced TFEB deacetylation by SIRT1 promotes autophagy in peritoneal macrophages","volume":"13","author":"Zheng","year":"2021","journal-title":"Aging"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40001-023-01623-4","article-title":"Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+\/SIRT1\/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism","volume":"29","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.18632\/aging.101469","article-title":"Loss of NAMPT in aging retinal pigment epithelium reduces NAD+ availability and promotes cellular senescence","volume":"10","author":"Jadeja","year":"2018","journal-title":"Aging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Feige","year":"2009","journal-title":"Nature"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Carollo, C., Sorce, A., Cirafici, E., Mul\u00e8, G., and Caimi, G. (2025). Sirtuins and resveratrol in cardiorenal diseases: A narrative review of mechanisms and therapeutic potential. Nutrients, 17.","DOI":"10.20944\/preprints202503.1085.v1"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1074\/jbc.M109.088682","article-title":"SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1","volume":"285","author":"Pacholec","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/biof.1032","article-title":"Sirtuin activators and inhibitors","volume":"38","author":"Villalba","year":"2012","journal-title":"Biofactors"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature06261","article-title":"Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes","volume":"450","author":"Milne","year":"2007","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9282484","DOI":"10.1155\/2022\/9282484","article-title":"Multiple roles of SIRT2 in regulating physiological and pathological signal transduction","volume":"2022","author":"Zhu","year":"2022","journal-title":"Genet. Res. (Camb.)"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Murugasamy, K., Munjal, A., and Sundaresan, N.R. (2022). Emerging roles of SIRT3 in cardiac metabolism. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.850340"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.18632\/aging.204690","article-title":"Exosomal miR-663b from \u201cM1\u201d macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK\/Sirt1 axis","volume":"15","author":"Ma","year":"2023","journal-title":"Aging"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/HYPERTENSIONAHA.116.08184","article-title":"Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity","volume":"68","author":"Varshney","year":"2016","journal-title":"Hypertension"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/etm.2020.9309","article-title":"SIRT1 promotes pulmonary artery endothelial cell proliferation by targeting the Akt signaling pathway","volume":"20","author":"Xi","year":"2020","journal-title":"Exp. Ther. Med"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000477115","article-title":"Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1","volume":"42","author":"Yu","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Liu, H., Pan, Z., Wu, X., Gong, C., and Hu, J. (2024). Jagged 2 inhibition attenuates hypoxia-induced mitochondrial damage and pulmonary hypertension through Sirtuin 1 signaling. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0297525"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/FJC.0000000000000224","article-title":"Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats","volume":"65","author":"Ding","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Zhou, S., Li, M.T., Jia, Y.Y., Liu, J.J., Wang, Q., Tian, Z., Liu, Y.T., Chen, H.Z., Liu, D.P., and Zeng, X.F. (2015). Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/762349"},{"key":"ref_112","first-page":"1841527","article-title":"Resveratrol Prevents Right Ventricle Remodeling and Dysfunction in Monocrotaline-Induced Pulmonary Arterial Hypertension with a Limited Improvement in the Lung Vasculature","volume":"2020","author":"Lozano","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2125.2012.04340.x","article-title":"Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man","volume":"75","author":"Hoffmann","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/eurheartj\/ehu095","article-title":"The Sirt1 activator SRT3025 provides atheroprotection in Apoe-\/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression","volume":"36","author":"Miranda","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/MCB.26.1.28-38.2006","article-title":"Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage","volume":"26","author":"Solomon","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/1087057111420291","article-title":"Advances in label-free screening approaches for studying sirtuin-mediated deacetylation","volume":"16","author":"Rye","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1254\/jphs.08203FP","article-title":"A novel chalcone polyphenol inhibits the deacetylase activity of SIRT1 and cell growth in HEK293T cells","volume":"108","author":"Kahyo","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"38837","DOI":"10.1074\/jbc.M106779200","article-title":"Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening","volume":"276","author":"Grozinger","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccr.2008.03.004","article-title":"Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator","volume":"13","author":"Lain","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/cmdc.200700003","article-title":"Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins)","volume":"2","author":"Trapp","year":"2007","journal-title":"ChemMedChem"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1039\/D3MD00489A","article-title":"Sirtuin 1-activating derivatives belonging to the anilinopyridine class displaying in vivo cardioprotective activities","volume":"15","author":"Bononi","year":"2023","journal-title":"RSC Med. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Campagna, R., Mazzanti, L., Pompei, V., Alia, S., Vignini, A., and Emanuelli, M. (2024). The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update. Cells, 13.","DOI":"10.3390\/cells13171469"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/cvr\/cvy212","article-title":"Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells","volume":"115","author":"Guo","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7150\/ijbs.78654","article-title":"Novel Role of the SIRT1 in Endocrine and Metabolic Diseases","volume":"19","author":"Lu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_125","first-page":"e12735","article-title":"A Paradigm Shift in the Management of Atherosclerosis: Protective Role of Sirtuins in Atherosclerosis","volume":"13","author":"Toulassi","year":"2021","journal-title":"Cureus"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpha.2023.09.001","article-title":"The potential of herbal drugs to treat heart failure: The roles of Sirt1\/AMPK","volume":"14","author":"Zhang","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/jcmm.16329","article-title":"Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1\/FoxO3a pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"106957","DOI":"10.1016\/j.phrs.2023.106957","article-title":"SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion","volume":"199","author":"Ding","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1035387","DOI":"10.3389\/fphar.2022.1035387","article-title":"SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity","volume":"13","author":"Podyacheva","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.14336\/AD.2021.0927","article-title":"Cellular Senescence in Cardiovascular Diseases: A Systematic Review","volume":"13","author":"Hu","year":"2022","journal-title":"Aging Dis."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Zheng, S., Yang, L., Dai, Q., Li, X., Masuoka, T., and Lv, J. (2025). Role of sirtuin 1 in depression-induced coronary heart disease: Molecular pathways and therapeutic potential (Review). Biomed. Rep., 22.","DOI":"10.3892\/br.2025.1924"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/aps.2017.50","article-title":"Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1\u03b1 deacetylation","volume":"39","author":"Fang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1073\/pnas.1934713100","article-title":"Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice","volume":"100","author":"Cheng","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12933-023-02040-x","article-title":"SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1","volume":"22","author":"Wang","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"14855","DOI":"10.1073\/pnas.0704329104","article-title":"SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase","volume":"104","author":"Mattagajasingh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"E932","DOI":"10.1152\/ajpendo.00051.2020","article-title":"Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP\/HIF1\u03b1\/VEGFA depletion","volume":"319","author":"Pan","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4070\/kcj.2023.0197","article-title":"Dronedarone Attenuates Ang II-Induced Myocardial Hypertrophy Through Regulating SIRT1\/FOXO3\/PKIA Axis","volume":"54","author":"Chen","year":"2024","journal-title":"Korean Circ. J."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Yang, J., Li, L., Zheng, X., Lu, Z., and Zhou, H. (2023). Dapagliflozin attenuates myocardial hypertrophy via activating the SIRT1\/HIF-1\u03b1 signaling pathway. Biomed. Pharmacother., 165.","DOI":"10.1016\/j.biopha.2023.115125"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5554569","DOI":"10.1155\/2021\/5554569","article-title":"Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1","volume":"2021","author":"Jiang","year":"2021","journal-title":"Cardiovasc. Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajpath.2016.09.016","article-title":"Sirtuin 1 Activation Reduces Transforming Growth Factor-\u03b21-Induced Fibrogenesis and Affords Organ Protection in a Model of Progressive, Experimental Kidney and Associated Cardiac Disease","volume":"187","author":"Zhang","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"14382","DOI":"10.1080\/21655979.2022.2085583","article-title":"\u03b2-aminoisobutyric acid ameliorates hypertensive vascular remodeling via activating the AMPK\/SIRT1 pathway in VSMCs","volume":"13","author":"Yin","year":"2022","journal-title":"Bioengineered"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cvr\/cvy131","article-title":"Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2\/3 transactivation","volume":"114","author":"Ford","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/HYPERTENSIONAHA.116.07709","article-title":"Activation of SIRT1 Attenuates Klotho Deficiency-Induced Arterial Stiffness and Hypertension by Enhancing AMP-Activated Protein Kinase Activity","volume":"68","author":"Gao","year":"2016","journal-title":"Hypertension"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s43188-023-00207-y","article-title":"Phloretin targets SIRT1 to alleviate oxidative stress, apoptosis, and inflammation in deep venous thrombosis","volume":"40","author":"Wang","year":"2023","journal-title":"Toxicol. Res."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Pai, P.Y., Wong, J.K.S., Cui, Z.Y., Lin, Y.Y., and Lee, S.D. (2022). Angiotensin II Receptor Blocker Irbesartan Enhanced SIRT1 longevity Signaling Replaces the Mitochondrial Biogenetic Survival Pathway to Attenuate Hypertension-Induced Heart Apoptosis. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9080266"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Han, Y., Sun, W., Ren, D., Zhang, J., He, Z., Fedorova, J., Sun, X., Han, F., and Li, J. (2020). SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion. Redox Biol., 34.","DOI":"10.1016\/j.redox.2020.101538"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/jcmm.15904","article-title":"Echinacoside reverses myocardial remodeling and improves heart function via regulating SIRT1\/FOXO3a\/MnSOD axis in HF rats induced by isoproterenol","volume":"25","author":"Ni","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Zhu, H.Z., Zhang, L.Y., Zhai, M.E., Xia, L., Cao, Y., Xu, L., Li, K.F., Jiang, L.Q., Shi, H., and Li, X. (2021). GDF11 Alleviates Pathological Myocardial Remodeling in Diabetic Cardiomyopathy Through SIRT1-Dependent Regulation of Oxidative Stress and Apoptosis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.686848"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Hao, Z., Xu, G., Yuan, M., Tan, R., Xia, Y., Liu, Y., and Yin, X. (2022). Leucine Supplementation in Middle-Aged Male Mice Improved Aging-Induced Vascular Remodeling and Dysfunction via Activating the Sirt1-Foxo1 Axis. Nutrients, 14.","DOI":"10.3390\/nu14183856"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/cvr\/cvad102","article-title":"Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress","volume":"119","author":"Yang","year":"2023","journal-title":"Cardiovasc Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7049237","DOI":"10.1155\/2019\/7049237","article-title":"Cardiac rehabilitation increases SIRT1 activity and \u03b2-hydroxybutyrate levels and decreases oxidative stress in patients with HF with preserved ejection fraction","volume":"2019","author":"Corbi","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Pei, J., Liu, Z., Wang, C., Chu, N., Liu, L., Tang, Y., Liu, H., Xiang, Q., Cheng, H., and Li, M. (2022). Progesterone Attenuates SIRT1-Deficiency-Mediated Pre-Eclampsia. Biomolecules, 12.","DOI":"10.3390\/biom12030422"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5551\/jat.47993","article-title":"Estrogen-SIRT1 Axis Plays a Pivotal Role in Protecting Arteries Against Menopause-Induced Senescence and Atherosclerosis","volume":"27","author":"Sasaki","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Karolczak, K., and Watala, C. (2023). Estradiol as the Trigger of Sirtuin-1-Dependent Cell Signaling with a Potential Utility in Anti-Aging Therapies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241813753"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bph.12290","article-title":"17-\u03b2 Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1\/AMPK\/H3 acetylation","volume":"170","author":"Bendale","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","article-title":"Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats","volume":"54","author":"Csiszar","year":"2009","journal-title":"Hypertension"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Tang, H., Ning, K., Wu, B., Wang, X., He, J., Li, P., Pan, L., Zhang, J., He, Y., and Bian, S. (2025). Scutellarein ameliorates pulmonary arterial hypertension via sirtuin 1 mediated deacetylation of nicotinamide nucleotide transhydrogenase. Biochem. Pharmacol., 237.","DOI":"10.1016\/j.bcp.2025.116932"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.18632\/aging.205468","article-title":"Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress","volume":"16","author":"Chai","year":"2024","journal-title":"Aging"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vph.2011.11.002","article-title":"Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: A potential role for atrogin-1 in smooth muscle","volume":"56","author":"Paffett","year":"2012","journal-title":"Vascul Pharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.biopha.2018.07.166","article-title":"15-HETE protects pulmonary artery smooth muscle cells against apoptosis via SIRT1 regulation during hypoxia","volume":"108","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s43450-024-00573-0","article-title":"Shionone Exhibits Anti-inflammatory and Antiproliferative Effects in Pulmonary Arterial Endothelial Cells and Smooth Muscle Cells via SIRT1 in Pulmonary Arterial Hypertension","volume":"34","author":"Jiang","year":"2024","journal-title":"Rev. Bras. Farmacogn."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.121.319971","article-title":"The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure","volume":"130","author":"Boucherat","year":"2022","journal-title":"Circ. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4939-8597-5_18","article-title":"Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration","volume":"1816","author":"Sassi","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41440-021-00660-y","article-title":"Pulmonary arterial hypertension induces the release of circulating extracellular vesicles with oxidative content and alters redox and mitochondrial homeostasis in the brains of rats","volume":"44","author":"Corssac","year":"2021","journal-title":"Hypertens. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ame2.12220","article-title":"Experimental animal models of pulmonary hypertension: Development and challenges","volume":"5","author":"Wu","year":"2022","journal-title":"Anim. Models Exp. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/jamp.2024.0016","article-title":"Current Overview of the Biology and Pharmacology in Sugen\/Hypoxia-Induced Pulmonary Hypertension in Rats","volume":"37","author":"Corboz","year":"2024","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4049\/jimmunol.1900535","article-title":"RELM\u03b1 Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling","volume":"203","author":"Lin","year":"2019","journal-title":"J. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"8759","DOI":"10.1080\/21655979.2022.2036302","article-title":"Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p\/protein kinase-B3 axis","volume":"13","author":"Jing","year":"2022","journal-title":"Bioengineered"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pathophys.2016.05.004","article-title":"Resveratrol prevents pulmonary trunk remodeling but not right ventricular hypertrophy in monocrotaline-induced pulmonary hypertension","volume":"23","author":"Wilson","year":"2016","journal-title":"Pathophysiology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e97530","DOI":"10.1172\/jci.insight.97530","article-title":"Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase","volume":"3","author":"Klinke","year":"2018","journal-title":"JCI Insight"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2017.12.035","article-title":"SIRT1 and HIF1\u03b1 signaling in metabolism and immune responses","volume":"418","author":"Yu","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvq376","article-title":"Sirt1 acts in association with PPAR\u03b1 to protect the heart from hypertrophy, metabolic dysregulation, and inflammation","volume":"90","author":"Planavila","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.intimp.2018.11.054","article-title":"SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 promoter region","volume":"67","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1080\/15384101.2020.1788251","article-title":"SIRT1 relieves Necrotizing Enterocolitis through inactivation of Hypoxia-inducible factor (HIF)-1a","volume":"19","author":"Bai","year":"2020","journal-title":"Cell Cycle"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ. Res."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Elibol, B., and Kilic, U. (2018). High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00614"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Salla, M., Karaki, N., El Kaderi, B., Ayoub, A.J., Younes, S., Abou Chahla, M.N., Baksh, S., and El Khatib, S. (2024). Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16040569"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Chimento, A., De Amicis, F., Sirianni, R., Sinicropi, M.S., Puoci, F., Casaburi, I., Saturnino, C., and Pezzi, V. (2019). Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061381"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Wang, J., Liu, T., Chen, P., Yin, D., Zhang, H., Qiu, X., Zou, S., and Li, W. (2025). Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-08665-0"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2010.05853.x","article-title":"Clinical trials of resveratrol","volume":"1215","author":"Patel","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/mnfr.200800177","article-title":"Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers","volume":"53","author":"Almeida","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jfda.2016.07.004","article-title":"Biological actions and molecular effects of resveratrol, pterostilbene, and 3\u2032-hydroxypterostilbene","volume":"25","author":"Tsai","year":"2017","journal-title":"J. Food Drug Anal."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Reddy, R., Kalra, S.S., Alzghoul, B., Khan, A., and Zayed, Y. (2023). Effect of Obesity on Mortality in Pulmonary Hypertension-A Systematic Review and Meta-Analysis. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10100419"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11357-016-9917-y","article-title":"Common SIRT1 variants modify the effect of abdominal adipose tissue on aging-related lung function decline","volume":"38","author":"Curjuric","year":"2016","journal-title":"Age"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/18\/3740\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:05Z","timestamp":1760035565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/18\/3740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":185,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["molecules30183740"],"URL":"https:\/\/doi.org\/10.3390\/molecules30183740","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}